Terifrac 750mcg-6s (Teriparatide Cartridge) 750mcg/3ml

Terifrac 750mcg-6s is a teriparatide cartridge designed for osteoporosis management. This injectable formulation supports bone health in adults with high fracture risk. Store refrigerated between 2-8°C to maintain potency. Suitable for patients seeking osteoporosis treatment options.

Strength

750mcg/3ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Intas Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Teriparatide cartridge 750mcg/3ml is used to treat osteoporosis in postmenopausal women and men at high risk of fracture. It stimulates new bone formation to strengthen skeletal structure. Patients often ask what teriparatide is used for when considering treatment options for bone density loss. The 6-cartridge pack provides convenient monthly supply for consistent therapy.

Side Effects

Terifrac cartridge delivers teriparatide to support bone mineral density improvement over time. Users may notice gradual enhancement in skeletal strength with regular use. Some individuals report improved mobility as bone health stabilizes. Effects vary by patient response and treatment duration.

Precautions & Warnings

Keep Terifrac refrigerated at 2-8°C to preserve medication integrity. Protect from light and avoid freezing. Discard if solution appears cloudy or contains particles. Do not use beyond expiration date printed on packaging. Consult healthcare provider before starting or stopping therapy.

Avoid Interactions

Teriparatide may interact with digoxin or other medications affecting calcium metabolism. Concurrent use with corticosteroids can reduce bone-building effects. Alcohol consumption may impact bone density improvement. Always inform healthcare provider about all medications being taken.

References

Frequently Asked Questions

Teriparatide is used to treat osteoporosis in adults at high risk of fracture by stimulating new bone formation.

Store Terifrac refrigerated between 2-8°C and protect from light. Do not freeze or expose to extreme temperatures.

Long-term use should be discussed with a healthcare provider as treatment duration varies by individual bone health needs.

Common effects may include dizziness, joint pain, or nausea, which should be reported to a healthcare provider if persistent.

Yes, teriparatide is approved for treating osteoporosis in both postmenopausal women and men at high fracture risk.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.